Interacting Drugs |
Sitagliptin vs ACE Inhibitors |
Security Level |
 |
Mechanism |
ACE Inhibitors: DPP-IV Inhibitors may enhance the adverse/toxic effect of ACE Inhibitors. Specifically, the risk of angioedema may be increased. |
Management |
Monitor therapy |
Sitagliptin vs ACE Inhibitors
Post Review about Sitagliptin vs ACE Inhibitors Click here to cancel reply.
Other Interactions of Sitagliptin
Other Interactions of ACE Inhibitors
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.